Skip to main content
Erschienen in: Acta Neurochirurgica 12/2013

01.12.2013 | Clinical Article - Brain Tumors

Postsurgical screening for psychosocial disorders in neurooncological patients

verfasst von: M. Renovanz, A. Gutenberg, M. Haug, E. Strittmatter, J. Mazur, M. Nadji-Ohl, A. Giese, N. Hopf

Erschienen in: Acta Neurochirurgica | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

The diagnosis of a brain tumor can cause severe psychosocial distress, which can have a variety of negative consequences on patients' physical and mental well-being. The detection of psychosocial distress in daily clinical routine is difficult and subsequent referral to mental health professionals is rare. The aim of this study was to determine the incidence of psychological disorders of patients early postoperatively and to investigate both the Hornheide Screening Instrument (HSI) and Distress Thermometer (DT) as screening tools in neurooncological practice.

Methods

One hundred and thirty-four patients with brain tumors of different histology were postoperatively evaluated by the Distress Thermometer and Hornheide Screening Instrument. Additionally, correlation to gender, age, localization of the tumor, Karnofsky performance score and tumor entity were analyzed.

Results

After initial surgery 36 patients (26.9 %) showed pathologic results in the HSI and 50 patients (36.7 %) were severely distressed (DT Score ≥ 6). Women had the highest rate of psychological disorders, followed by patients suffering from gliomas and meningiomas. Further highlighting the results of both tests, over 80 % of those patients who scored pathologically in both tests were in need of professional psychiatric help due to depression.

Conclusion

Both the DT and HSI are suitable instruments for identifying patients in psychological distress after brain tumor surgery in neurooncological routine. Our results confirm that nearly one third of patients are unable to overcome the difficulties facing the diagnosis of a brain tumor in this early situation and should be supported by mental health professionals.
Literatur
1.
Zurück zum Zitat Angenendt G, Schütze-Kreilkamp U, Tschuschke von Haug V (2010) Praxis der Psychoonkologie: Psychoedukation, Beratung und Therapie. Stuttgart,pp 13–18 Angenendt G, Schütze-Kreilkamp U, Tschuschke von Haug V (2010) Praxis der Psychoonkologie: Psychoedukation, Beratung und Therapie. Stuttgart,pp 13–18
2.
Zurück zum Zitat Arnold SD, Forman LM, Brigidi BD, Carter KE, Schweitzer HA, Quinn HE, Guill AB, Herdon JE 2nd, Raynor RH (2008) Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol 10(2):171–181PubMedCrossRef Arnold SD, Forman LM, Brigidi BD, Carter KE, Schweitzer HA, Quinn HE, Guill AB, Herdon JE 2nd, Raynor RH (2008) Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol 10(2):171–181PubMedCrossRef
3.
Zurück zum Zitat Acquaye AA, Vera-Bolanos E, Armstrong TS, Gilbert MR, Lin L (2013) Mood disturbance in glioma patients. J Neurooncol 113(3):505–512PubMedCrossRef Acquaye AA, Vera-Bolanos E, Armstrong TS, Gilbert MR, Lin L (2013) Mood disturbance in glioma patients. J Neurooncol 113(3):505–512PubMedCrossRef
4.
Zurück zum Zitat Bullinger M, Siegrist J (2000). Entwicklung und klinischer Einsatz von Screening-Instrumenten zur Identifikation betreuungsbedürftiger Tumorpatienten. Lebensqualitätsforschung aus medizinpsychologischer und - soziologischer Perspektive. Jahrbuch der Medizinischen Psychologie, pp. 59–75 Bullinger M, Siegrist J (2000). Entwicklung und klinischer Einsatz von Screening-Instrumenten zur Identifikation betreuungsbedürftiger Tumorpatienten. Lebensqualitätsforschung aus medizinpsychologischer und - soziologischer Perspektive. Jahrbuch der Medizinischen Psychologie, pp. 59–75
5.
Zurück zum Zitat Fischbeck S, Kohlhof H, Hardt J, Hertel F, Wiewrodt D (2011) Burden and need for psychosocial intervention of glioblastoma patients. Psychother Psychosom Med Psychol 61(12):518–524PubMedCrossRef Fischbeck S, Kohlhof H, Hardt J, Hertel F, Wiewrodt D (2011) Burden and need for psychosocial intervention of glioblastoma patients. Psychother Psychosom Med Psychol 61(12):518–524PubMedCrossRef
6.
Zurück zum Zitat Flanigan JC, Jilaveanu LB, Chiang VL, Kluger HM (2013) Advances in therapy for melanoma brain metastases. Clin Dermatol 31(3):264–281PubMedCrossRef Flanigan JC, Jilaveanu LB, Chiang VL, Kluger HM (2013) Advances in therapy for melanoma brain metastases. Clin Dermatol 31(3):264–281PubMedCrossRef
7.
Zurück zum Zitat Goebel S, Stark AM, Kaup L, Von Harscher M, Mehdorn HM (2011) Distress in patients with newly diagnosed brain tumours. Psychooncology 20(6):623–630PubMedCrossRef Goebel S, Stark AM, Kaup L, Von Harscher M, Mehdorn HM (2011) Distress in patients with newly diagnosed brain tumours. Psychooncology 20(6):623–630PubMedCrossRef
8.
Zurück zum Zitat Goebel S, Mehdorn HM (2011) Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer. J Neurooncol 104(1):357–364PubMedCrossRef Goebel S, Mehdorn HM (2011) Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer. J Neurooncol 104(1):357–364PubMedCrossRef
9.
Zurück zum Zitat Goebel S, Kaup L, Wiesner CD, Mehdorn HM (2013) Affective state and cognitive functioning in patients with intracranial tumors: validity of the neuropsychological baseline assessment. Psychooncology 22(6):1319–1327PubMedCrossRef Goebel S, Kaup L, Wiesner CD, Mehdorn HM (2013) Affective state and cognitive functioning in patients with intracranial tumors: validity of the neuropsychological baseline assessment. Psychooncology 22(6):1319–1327PubMedCrossRef
10.
Zurück zum Zitat Herschbach P, Heußner P, Sellschopp A (2006). Screening-Instrumente zur Ermittlung der Betreuungsbedürftigkeit von Tumorpatienten. Psychoonkologie. Perspektiven heute, pp. 122–142 Herschbach P, Heußner P, Sellschopp A (2006). Screening-Instrumente zur Ermittlung der Betreuungsbedürftigkeit von Tumorpatienten. Psychoonkologie. Perspektiven heute, pp. 122–142
11.
Zurück zum Zitat Keir ST, Calhoun-Eagan RD, Swartz JJ, Saleh OA, Friedman HS (2008) Screening for distress in patients with brain cancer using the NCCN’s rapid screening measure. Psychooncology 17(6):621–625PubMedCrossRef Keir ST, Calhoun-Eagan RD, Swartz JJ, Saleh OA, Friedman HS (2008) Screening for distress in patients with brain cancer using the NCCN’s rapid screening measure. Psychooncology 17(6):621–625PubMedCrossRef
12.
Zurück zum Zitat Keir ST, Farland MM, Lipp ES, Friedman HS (2008) Distress persists in long-term brain tumor survivors with glioblastoma multiforme. J Cancer Surviv 2(4):269–274PubMedCrossRef Keir ST, Farland MM, Lipp ES, Friedman HS (2008) Distress persists in long-term brain tumor survivors with glioblastoma multiforme. J Cancer Surviv 2(4):269–274PubMedCrossRef
13.
Zurück zum Zitat Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM (2006) American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24:2932–2947PubMedCrossRef Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM (2006) American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24:2932–2947PubMedCrossRef
14.
Zurück zum Zitat Kvale EA, Murthy R, Taylor R, Lee JY, Nabors LB (2009) Distress and quality of life in primary high-grade brain tumor patients. Support Care Cancer 17(7):793–799PubMedCrossRef Kvale EA, Murthy R, Taylor R, Lee JY, Nabors LB (2009) Distress and quality of life in primary high-grade brain tumor patients. Support Care Cancer 17(7):793–799PubMedCrossRef
15.
16.
Zurück zum Zitat Linden W, Vodermaier A, Mackenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141(2–3):343–351PubMedCrossRef Linden W, Vodermaier A, Mackenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141(2–3):343–351PubMedCrossRef
17.
Zurück zum Zitat Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER (2004) Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurg 54(2):358–366CrossRef Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER (2004) Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurg 54(2):358–366CrossRef
18.
Zurück zum Zitat Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2009) Somatization symptoms are related to right-hemispheric primary brain tumor: a population-based prospective study of tumor patients in northern Finland. Psychosomatics 50(4):331–335PubMedCrossRef Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2009) Somatization symptoms are related to right-hemispheric primary brain tumor: a population-based prospective study of tumor patients in northern Finland. Psychosomatics 50(4):331–335PubMedCrossRef
19.
Zurück zum Zitat Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2006) Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatry 21(3):194–199PubMedCrossRef Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2006) Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatry 21(3):194–199PubMedCrossRef
20.
Zurück zum Zitat Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2011) Depression in relation to anxiety, obsessionality and phobia among neurosurgical patients with a primary brain tumor: a 1-year follow-up study. Clin Neurol Neurosurg 113(8):649–653PubMedCrossRef Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2011) Depression in relation to anxiety, obsessionality and phobia among neurosurgical patients with a primary brain tumor: a 1-year follow-up study. Clin Neurol Neurosurg 113(8):649–653PubMedCrossRef
21.
Zurück zum Zitat Mainio A, Tuunanen S, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2006) Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci 256(8):516–521PubMedCrossRef Mainio A, Tuunanen S, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2006) Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci 256(8):516–521PubMedCrossRef
22.
Zurück zum Zitat Mehnert A, Lehmann C, Schulte T, Koch U (2007) Presence of symptom distress and prostate cancer-related anxiety in patients at the beginning of cancer rehabilitation. Onkologie 30(11):551–556PubMedCrossRef Mehnert A, Lehmann C, Schulte T, Koch U (2007) Presence of symptom distress and prostate cancer-related anxiety in patients at the beginning of cancer rehabilitation. Onkologie 30(11):551–556PubMedCrossRef
23.
Zurück zum Zitat Patten SB, Neutel CI (2000) Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 22:111–122PubMedCrossRef Patten SB, Neutel CI (2000) Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 22:111–122PubMedCrossRef
24.
Zurück zum Zitat Pringle AM, Taylor R, Whittle IR (1999) Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 13(1):46–51PubMedCrossRef Pringle AM, Taylor R, Whittle IR (1999) Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 13(1):46–51PubMedCrossRef
26.
Zurück zum Zitat Rooney AG, Carson A, Grant R (2011) Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst 103(1):61–76PubMedCrossRef Rooney AG, Carson A, Grant R (2011) Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst 103(1):61–76PubMedCrossRef
27.
Zurück zum Zitat Rumpold G, Augustin M, Zschocke I, Strittmatter G, Söllner W (2001) The validity of the Hornheide questionnaire for psychosocial support in skin tumor patients: a survey in an Austrian and German outpatient population with melanoma. Psychother Psychosom Med Psychol 51(1):25–33PubMedCrossRef Rumpold G, Augustin M, Zschocke I, Strittmatter G, Söllner W (2001) The validity of the Hornheide questionnaire for psychosocial support in skin tumor patients: a survey in an Austrian and German outpatient population with melanoma. Psychother Psychosom Med Psychol 51(1):25–33PubMedCrossRef
28.
Zurück zum Zitat Shuch B, La Rochelle JC, Klatte T, Riggs SB, Liu W, Kabbinavar FF, Pantuck AJ, Belldegrun AS (2008) Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer 113(7):1641–1648PubMedCrossRef Shuch B, La Rochelle JC, Klatte T, Riggs SB, Liu W, Kabbinavar FF, Pantuck AJ, Belldegrun AS (2008) Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer 113(7):1641–1648PubMedCrossRef
29.
Zurück zum Zitat Strittmatter G, Tilkorn M, Mawick R (2002) How to identify patients in need of psychological intervention. Recent Results Cancer Res 160:353–361PubMedCrossRef Strittmatter G, Tilkorn M, Mawick R (2002) How to identify patients in need of psychological intervention. Recent Results Cancer Res 160:353–361PubMedCrossRef
30.
Zurück zum Zitat Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996PubMedCrossRef Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996PubMedCrossRef
31.
Zurück zum Zitat Taillibert S, Laigle-Donadey F, Sanson M (2004) Palliative care in patients with primary brain tumors. Curr Opin Oncol 16(6):587–592PubMedCrossRef Taillibert S, Laigle-Donadey F, Sanson M (2004) Palliative care in patients with primary brain tumors. Curr Opin Oncol 16(6):587–592PubMedCrossRef
32.
Zurück zum Zitat Tilkorn M, Mawick R, Sommerfeld S, Strittmatter G (1990) Quality of life of patients with malignant facial and skin tumors-development of a questionnaire and initial findings of a study. Die Rehabil (Stuttg) 29(2):134–139 Tilkorn M, Mawick R, Sommerfeld S, Strittmatter G (1990) Quality of life of patients with malignant facial and skin tumors-development of a questionnaire and initial findings of a study. Die Rehabil (Stuttg) 29(2):134–139
33.
Zurück zum Zitat Warrington TP, Bostwick JM (2006) Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 81:1361–1367PubMedCrossRef Warrington TP, Bostwick JM (2006) Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 81:1361–1367PubMedCrossRef
34.
Zurück zum Zitat Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS (2005) Breast cancer metastasis to the central nervous system. Am J Pathol 167(4):913–920PubMedCrossRef Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS (2005) Breast cancer metastasis to the central nervous system. Am J Pathol 167(4):913–920PubMedCrossRef
35.
Zurück zum Zitat Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27(35):5874–5880PubMedCrossRef Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27(35):5874–5880PubMedCrossRef
Metadaten
Titel
Postsurgical screening for psychosocial disorders in neurooncological patients
verfasst von
M. Renovanz
A. Gutenberg
M. Haug
E. Strittmatter
J. Mazur
M. Nadji-Ohl
A. Giese
N. Hopf
Publikationsdatum
01.12.2013
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 12/2013
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-013-1884-9

Weitere Artikel der Ausgabe 12/2013

Acta Neurochirurgica 12/2013 Zur Ausgabe

Experimental research - Neurosurgical Anatomy

Three dimensional anatomy of the human nucleus accumbens

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.